Ravinder Heights Limited
Serum Institute of India decreased its stake in Ravinder Heights Limited from 4.34% to 3.32%, selling 621,940 shares.
A real estate developer engaged in residential and commercial property projects across India, the company specializes in township development and housing construction. Incorporated in 2019, it operates in the property development sector, delivering mixed-use projects that combine residential spaces with commercial facilities. The company targets middle to upper-income segments through planned township developments, housing initiatives, and integrated community spaces designed for long-term habitation.
World's largest vaccine manufacturer by volume, producing over 1.5 billion doses a year and reaching an estimated 65% of the world's children with at least one of its vaccines. Standalone revenue of Rs 10,900 crore in FY25. The Poonawalla family deploys surplus cash flow into Indian listed equities across pharma, financial services and consumer names, with Adar Poonawalla personally tracked as one of India's most aggressive private investors.